Drizalma Sprinkle (duloxetine delayed-release capsules) for oral use is indicated for the treatment of major depressive disorder in adults; generalized anxiety disorder in adults and pediatric ...

(2021-03-09) Sun Pharma Announces Drizalma Sprinkle(TM) (duloxetine delayed-release capsules) is Now Covered by Most Medicare Part D Plans Stockhouse.com uses cookies on this site. By continuing to ...

(RTTNews) - India- based Sun Pharmaceutical Industries Ltd. (SUNPHARMA, 524715) announced Wednesday the launch of Drizalma Sprinkle (duloxetine delayed-release capsules) in the U.S. for oral use.

233,000 bottles of duloxetine, the generic name for a popular antidepressant, were recently recalled. Here's what to know about the medication. Hotspots ranked Start the day smarter ☀️ ...

More than 233,000 bottles of an antidepressant have been recalled by the FDA due to the presence of duloxetine posing the risk of cancer. Hotspots ranked Start the day smarter ☀️ Funniest cap ...

Towa issued the recall for 7,107 bottles, which covers 500-count bottles of 20mg Duloxetine Delayed-Release Capsules, Lot number: 220128, Exp. Date 12/2024, according to the Oct. 11 Class II recall. 3 ...

More than 233,000 bottles of duloxetine capsules sold by Rising Pharmaceuticals were voluntarily recalled on Nov. 19, and the U.S. Food and Drug Administration assigned the recall as a class II ...

Over 7,100 bottles of Duloxetine were recalled, including 500 delayed-release 20mg capsules. The lot number is 220128, and the expiration date is 12/2024, per the FDA report.

The recall, announced on October 10, affects only 20 mg Duloxetine Delayed-Release Capsules made by Towa Pharmaceutical Europe, targeting over 7,100 bottles with lot number 220128 and an ...

(RTTNews) - India- based Sun Pharmaceutical Industries Ltd. (SUNPHARMA, 524715) announced Wednesday the launch of Drizalma Sprinkle (duloxetine delayed-release capsules) in the U.S. for oral use ...